Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …

COVID-19 vaccines were developed and approved rapidly in response to the urgency
created by the pandemic. No specific regulations existed at the time they were marketed …

Importance Multiple cases of autoimmune and autoinflammatory diseases after COVID-19
have been reported. However, their incidences and risks have rarely been quantified …

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has captivated the globe's attention since its emergence in 2019. This highly …

A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-
mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking …

Purpose Owing to adverse event following immunization (AEFI) related to autoimmune
disorders and coronavirus disease 2019 (COVID-19) vaccines sharing common biological …

During the COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infected millions of people worldwide, with acute respiratory distress syndrome …

In response to the coronavirus disease 2019 pandemic, the coronavirus disease 2019
vaccine was rapidly developed and the effectiveness of the vaccine has been established …

More than 3 years have passed since the emergence of COVID-19. On 8 May 2023, COVID-
19 in Japan was downgraded to Category 5 by the Infectious Disease Control Law. In …

(1) Background: The safety of medicines has been receiving increased attention to ensure
that the risks of taking medicines do not outweigh the benefits. This is the reason why, over …